Header Logo

Connection

Melody Cobleigh to Quinolines

Back to Details
This is a "connection" page, showing publications Melody Cobleigh has written about Quinolines.
Melody Cobleigh
Connection Strength
0.050
Quinolines
  1. The Phase II MutHER Study of Neratinib Alone and in Combination with Fulvestrant in HER2-Mutated, Non-amplified Metastatic Breast Cancer. Clin Cancer Res. 2022 04 01; 28(7):1258-1267.
    View in: PubMed
    Score: 0.050
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.